179 related articles for article (PubMed ID: 29699510)
1. Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma.
Wu L; Blum W; Zhu CQ; Yun Z; Pecze L; Kohno M; Chan ML; Zhao Y; Felley-Bosco E; Schwaller B; de Perrot M
BMC Cancer; 2018 Apr; 18(1):471. PubMed ID: 29699510
[TBL] [Abstract][Full Text] [Related]
2. Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed.
Cortes-Dericks L; Carboni GL; Schmid RA; Karoubi G
Int J Oncol; 2010 Aug; 37(2):437-44. PubMed ID: 20596671
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C
Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
Deng XB; Xiao L; Wu Y; Jin F; Mossman B; Testa JR; Xiao GH
Int J Cancer; 2015 Jul; 137(2):481-90. PubMed ID: 25501304
[TBL] [Abstract][Full Text] [Related]
5. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model.
Wu L; Yun Z; Tagawa T; Rey-McIntyre K; Anraku M; de Perrot M
J Thorac Oncol; 2011 Sep; 6(9):1578-86. PubMed ID: 21642867
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 blockade expands infiltrating T cells and inhibits cancer cell repopulation during the intervals of chemotherapy in murine mesothelioma.
Wu L; Yun Z; Tagawa T; Rey-McIntyre K; de Perrot M
Mol Cancer Ther; 2012 Aug; 11(8):1809-19. PubMed ID: 22584123
[TBL] [Abstract][Full Text] [Related]
8. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas.
Shukla A; Miller JM; Cason C; Sayan M; MacPherson MB; Beuschel SL; Hillegass J; Vacek PM; Pass HI; Mossman BT
Clin Cancer Res; 2013 Apr; 19(8):2071-83. PubMed ID: 23446998
[TBL] [Abstract][Full Text] [Related]
14. Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines.
Skowron MA; Niegisch G; Fritz G; Arent T; van Roermund JG; Romano A; Albers P; Schulz WA; Hoffmann MJ
J Exp Clin Cancer Res; 2015 Nov; 34():144. PubMed ID: 26606927
[TBL] [Abstract][Full Text] [Related]
15. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
16. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
17. Characterization of side population cells in human malignant mesothelioma cell lines.
Kai K; D'Costa S; Yoon BI; Brody AR; Sills RC; Kim Y
Lung Cancer; 2010 Nov; 70(2):146-51. PubMed ID: 20493579
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
[TBL] [Abstract][Full Text] [Related]
19. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
20. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.
Panaccione A; Chang MT; Carbone BE; Guo Y; Moskaluk CA; Virk RK; Chiriboga L; Prasad ML; Judson B; Mehra S; Yarbrough WG; Ivanov SV
Clin Cancer Res; 2016 Apr; 22(8):2083-95. PubMed ID: 27084744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
